AUSTIN JOSIAH T
Insider CIK 932267 · NVGN Director, 10% owner · MEIP 10% owner · CHTP 10% owner · NONE Director, 10% owner · GDP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GDPMQ GOODRICH PETROLEUM CORP | S Sale deriv | 2016-10-07 | 2016-10-11 | 13,912 | — | $0 | 0 | SEC↗ |
| GDPMQ GOODRICH PETROLEUM CORP | S Sale | 2016-09-22 | 2016-10-11 | 316,319 | $0.01 | $3.2K | 323 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award deriv | 2015-12-18 | 2016-03-16 | 0 | — | $0 | 0 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award | 2015-12-18 | 2016-03-16 | 100,000 | — | $0 | 4,841,411 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | P Buy deriv | 2015-12-16 | 2015-12-18 | 13,912 | — | $0 | 13,912 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2015-12-16 | 2015-12-18 | 13,912 | — | $0 | 0 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2015-07-08 | 2016-03-16 | 66,667 | $200000.00 | $13.33B | 66,667 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-07-08 | 2016-03-16 | 90,910 | — | $0 | 4,741,411 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-06-30 | 2016-03-16 | 913,945 | — | $0 | 10,493,254 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | P Buy | 2015-06-18 | 2015-06-18 | 6,912 | $6.23 | $43.1K | 83,912 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | P Buy | 2015-06-17 | 2015-06-18 | 7,000 | $6.99 | $48.9K | 77,000 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | A Award | 2015-05-29 | 2015-06-02 | 63,636 | $2.75 | $175.0K | 153,242 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | A Award | 2015-05-29 | 2015-06-09 | 63,636 | $2.75 | $175.0K | 70,642 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-04-14 | 2016-03-16 | 1,712,333 | — | $0 | 14,229,810 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-03-31 | 2016-03-16 | 142,504 | — | $0 | 12,517,477 | SEC↗ |
| PRGB Protea Biosciences Group, | J Other | 2015-03-31 | 2016-03-16 | 5,700,248 | — | $0 | 12,374,973 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 2,850,124 | — | $0 | 11,455,333 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 0 | — | $0 | 0 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 0 | — | $0 | 0 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 2,850,124 | — | $0 | 11,455,333 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 712,531 | — | $0 | 712,531 | SEC↗ |
| PRGB Protea Biosciences Group, | C Conversion deriv | 2014-10-31 | 2014-11-04 | 712,531 | — | $0 | 712,531 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-11 | 2014-09-12 | 174,545 | $139636.00 | $24.37B | 11,892,680 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-11 | 2014-09-12 | 290,909 | $160000.00 | $46.55B | 11,718,135 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-11 | 2014-09-12 | 174,545 | $139636.00 | $24.37B | 11,892,680 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-09-11 | 2014-09-12 | 290,909 | $160000.00 | $46.55B | 11,718,135 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-14 | 2014-08-19 | 309,091 | $170000.00 | $52.55B | 11,241,771 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-14 | 2014-08-19 | 185,455 | $148364.00 | $27.51B | 11,427,226 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-14 | 2014-08-19 | 185,455 | $148364.00 | $27.51B | 11,427,226 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-08-14 | 2014-08-19 | 309,091 | $170000.00 | $52.55B | 11,241,771 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-11 | 2014-07-15 | 130,909 | $104727.00 | $13.71B | 10,932,680 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-11 | 2014-07-15 | 218,182 | $120000.00 | $26.18B | 10,801,771 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-11 | 2014-07-15 | 218,182 | $120000.00 | $26.18B | 10,801,771 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-07-11 | 2014-07-15 | 130,909 | $104727.00 | $13.71B | 10,932,680 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-30 | 2014-07-02 | 218,182 | $174546.00 | $38.08B | 10,571,214 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-30 | 2014-07-02 | 218,182 | $174546.00 | $38.08B | 10,571,214 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-30 | 2014-07-02 | 363,636 | $200000.00 | $72.73B | 10,353,032 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-30 | 2014-07-02 | 363,636 | $200000.00 | $72.73B | 10,353,032 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-20 | 2014-06-24 | 45,455 | $25000.00 | $1.14B | 9,962,123 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-20 | 2014-06-24 | 27,273 | $21818.00 | $595.04M | 9,989,396 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-20 | 2014-06-24 | 45,455 | $25000.00 | $1.14B | 9,962,123 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-20 | 2014-06-24 | 27,273 | $21818.00 | $595.04M | 9,989,396 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-06 | 2014-06-09 | 163,637 | $130909.00 | $21.42B | 9,916,668 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-06 | 2014-06-09 | 272,727 | $150000.00 | $40.91B | 9,753,031 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-06 | 2014-06-09 | 272,727 | $150000.00 | $40.91B | 9,753,031 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-06-06 | 2014-06-09 | 163,637 | $130909.00 | $21.42B | 9,916,668 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-29 | 2014-05-30 | 318,182 | $175000.00 | $55.68B | 9,289,395 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-29 | 2014-05-30 | 190,909 | $152727.00 | $29.16B | 9,480,304 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-29 | 2014-05-30 | 190,909 | $152727.00 | $29.16B | 9,480,304 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-29 | 2014-05-30 | 318,182 | $175000.00 | $55.68B | 9,289,395 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | A Award | 2014-05-20 | 2014-05-21 | 7,006 | $24.98 | $175.0K | 89,606 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-15 | 2014-05-16 | 90,909 | $50000.00 | $4.55B | 8,916,667 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-15 | 2014-05-16 | 54,546 | $46636.00 | $2.54B | 8,971,213 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-15 | 2014-05-16 | 54,546 | $46636.00 | $2.54B | 8,971,213 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-15 | 2014-05-16 | 90,909 | $50000.00 | $4.55B | 8,916,667 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-09 | 2014-05-12 | 181,818 | $100000.00 | $18.18B | 8,716,667 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-09 | 2014-05-12 | 181,818 | $100000.00 | $18.18B | 8,716,667 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-09 | 2014-05-12 | 109,091 | $87273.00 | $9.52B | 8,825,758 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-09 | 2014-05-12 | 109,091 | $87273.00 | $9.52B | 8,825,758 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-06 | 2014-05-12 | 90,909 | $50000.00 | $4.55B | 8,480,303 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-06 | 2014-05-12 | 90,909 | $50000.00 | $4.55B | 8,480,303 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-06 | 2014-05-12 | 54,546 | $46636.00 | $2.54B | 8,534,849 | SEC↗ |
| PRGB Protea Biosciences Group, | P Buy deriv | 2014-05-06 | 2014-05-12 | 54,546 | $46636.00 | $2.54B | 8,534,849 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-04 | 190,909 | $152728.00 | $29.16B | 8,377,019 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-04 | 190,909 | $152728.00 | $29.16B | 8,377,019 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-04 | 318,182 | $175000.00 | $55.68B | 8,186,110 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2014-04-02 | 2014-04-04 | 318,182 | $175000.00 | $55.68B | 8,186,110 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-12-30 | 2014-02-13 | 254,584 | $127292.00 | $32.41B | 7,809,970 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-12-30 | 2014-02-13 | 254,584 | $127292.00 | $32.41B | 7,809,970 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 127,292 | $95469.00 | $12.15B | 8,059,970 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 127,292 | $95469.00 | $12.15B | 8,059,970 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 254,584 | $127292.00 | $32.41B | 7,932,678 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-12-30 | 2014-02-13 | 254,584 | $127292.00 | $32.41B | 7,932,678 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-12-30 | 2014-02-13 | 254,584 | $0.50 | $127.3K | 6,674,725 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-12-30 | 2014-02-13 | 254,584 | $0.50 | $127.3K | 6,674,725 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-11-05 | 2013-11-06 | 23,922 | $6.01 | $143.8K | 385,749 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-11-04 | 2013-11-06 | 25,400 | $6.02 | $152.9K | 409,671 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-11-01 | 2014-02-13 | 2,271,694 | $1135847.23 | $2580.30B | 4,120,552 | SEC↗ |
| NONE Protea Biosciences Group, | C Conversion deriv | 2013-11-01 | 2014-02-13 | 2,271,694 | $1135847.23 | $2580.30B | 4,120,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 303,417 | $227563.00 | $69.05B | 7,678,094 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 100,000 | $50000.00 | $5.00B | 4,220,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 606,833 | $303417.00 | $184.12B | 7,374,677 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 606,833 | $303417.00 | $184.12B | 7,374,677 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 319,375 | $239531.00 | $76.50B | 6,767,844 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 319,375 | $239531.00 | $76.50B | 6,767,844 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 638,750 | $319375.00 | $204.00B | 6,448,469 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 638,750 | $319375.00 | $204.00B | 6,448,469 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 513,056 | $384792.00 | $197.42B | 5,809,719 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 513,056 | $384792.00 | $197.42B | 5,809,719 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 1,026,111 | $513056.00 | $526.45B | 5,296,663 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 1,026,111 | $513056.00 | $526.45B | 5,296,663 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 50,000 | $37500.00 | $1.88B | 4,270,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 50,000 | $37500.00 | $1.88B | 4,270,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 100,000 | $50000.00 | $5.00B | 4,220,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-11-01 | 2014-02-13 | 303,417 | $227563.00 | $69.05B | 7,678,094 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 638,750 | $0.50 | $319.4K | 5,813,308 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 100,000 | $0.50 | $50.0K | 4,148,447 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 606,833 | $0.50 | $303.4K | 6,420,141 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 606,833 | $0.50 | $303.4K | 6,420,141 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 638,750 | $0.50 | $319.4K | 5,813,308 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 1,026,111 | $0.50 | $513.1K | 5,174,558 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 1,026,111 | $0.50 | $513.1K | 5,174,558 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-11-01 | 2014-02-13 | 100,000 | $0.50 | $50.0K | 4,148,447 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-10-29 | 2013-10-29 | 1,100 | $6.04 | $6.6K | 435,071 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-10-28 | 2013-10-29 | 37,409 | $6.18 | $231.2K | 436,171 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-25 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 6,350,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-10-25 | 2014-02-13 | 250,000 | $125000.00 | $31.25B | 6,350,552 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-10-25 | 2013-10-29 | 62,591 | $6.17 | $386.2K | 473,580 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-10-15 | 2013-10-17 | 90,025 | $6.21 | $559.1K | 536,171 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-20 | 2013-10-01 | 0 | $300000.00 | $0 | 6,100,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-20 | 2013-10-01 | 0 | — | $0 | 6,100,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-20 | 2013-10-01 | 225,000 | $300000.00 | $67.50B | 6,100,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-20 | 2013-10-01 | 225,000 | — | $0 | 6,100,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-11 | 2013-09-16 | 0 | $315000.00 | $0 | 5,275,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-11 | 2013-09-16 | 0 | — | $0 | 5,275,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-11 | 2013-09-16 | 0 | $315000.00 | $0 | 5,275,552 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-09-11 | 2013-09-16 | 0 | — | $0 | 5,275,552 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2013-08-29 | 2013-08-30 | 297,536 | $21.48 | $6.39M | 1,900,790 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2013-08-28 | 2013-08-30 | 253,816 | $21.35 | $5.42M | 2,198,326 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2013-08-26 | 2013-08-27 | 90,731 | $21.58 | $1.96M | 2,452,142 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2013-08-23 | 2013-08-27 | 57,917 | $21.85 | $1.27M | 2,542,873 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2013-08-22 | 2013-08-27 | 300,000 | $21.93 | $6.58M | 2,600,790 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | P Buy | 2013-08-14 | 2013-08-20 | 70,000 | $25.00 | $1.75M | 70,000 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-29 | 2013-09-16 | 236,250 | $500000.00 | $118.13B | 4,409,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-29 | 2013-09-16 | 375,000 | — | $0 | 4,409,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-29 | 2013-09-16 | 236,250 | — | $0 | 4,409,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-07-29 | 2013-09-16 | 375,000 | $500000.00 | $187.50B | 4,409,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-06-30 | 2013-09-16 | 196,802 | — | $0 | 3,034,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-06-30 | 2013-09-16 | 196,802 | — | $0 | 3,034,302 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-06-30 | 2013-09-16 | 262,403 | $0.50 | $131.2K | 4,048,447 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-06-30 | 2013-09-16 | 262,403 | $0.50 | $131.2K | 4,048,447 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | A Award | 2013-05-21 | 2013-05-23 | 6,000 | $13.61 | $81.7K | 82,600 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-04-05 | 2013-06-14 | 210,000 | — | $0 | 3,275,000 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-04-05 | 2013-06-14 | 210,000 | — | $0 | 3,275,000 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | P Buy | 2013-04-05 | 2013-04-12 | 60,000 | $25.00 | $1.50M | 60,000 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-04-05 | 2013-06-14 | 280,000 | $0.50 | $140.0K | 3,786,044 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-04-05 | 2013-06-14 | 280,000 | $0.50 | $140.0K | 3,786,044 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-03-21 | 2013-03-25 | 1,027,500 | — | $0 | 3,065,000 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-03-21 | 2013-03-25 | 1,027,500 | — | $0 | 3,065,000 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-03-21 | 2013-03-25 | 1,370,000 | $0.50 | $685.0K | 3,506,044 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy | 2013-03-21 | 2013-03-25 | 1,370,000 | $0.50 | $685.0K | 3,506,044 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-26 | 2013-02-27 | 500 | $8.00 | $4.0K | 626,196 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $9.15 | $4.6K | 627,696 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $9.21 | $4.6K | 627,196 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $9.10 | $4.5K | 628,196 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $9.05 | $4.5K | 628,696 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $8.90 | $4.5K | 629,196 | SEC↗ |
| NVGN NOVOGEN LTD | S Sale | 2013-02-25 | 2013-02-27 | 500 | $9.03 | $4.5K | 626,696 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award deriv | 2013-01-28 | 2014-07-15 | 12,375 | $6806.00 | $84.22M | 10,583,589 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award deriv | 2013-01-28 | 2014-05-12 | 12,375 | $6806.00 | $84.22M | 8,389,394 | SEC↗ |
| NONE Protea Biosciences Group, | A Award deriv | 2013-01-28 | 2014-02-13 | 57,958 | $31877.00 | $1.85B | 7,867,928 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-01-03 | 2013-01-07 | 0 | — | $0 | 4,173,544 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-01-03 | 2013-01-07 | 187,500 | $125000.00 | $23.44B | 4,173,544 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-01-03 | 2013-01-07 | 187,500 | — | $0 | 4,173,544 | SEC↗ |
| NONE Protea Biosciences Group, | P Buy deriv | 2013-01-03 | 2013-01-07 | 0 | $125000.00 | $0 | 4,173,544 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2012-12-18 | 2012-12-19 | 50,000 | $9.21 | $460.5K | 2,900,790 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-17 | 2012-12-18 | 439,308 | $0.92 | $404.2K | 6,432,673 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-17 | 2012-12-19 | 439,308 | $0.92 | $404.2K | 6,432,673 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | S Sale | 2012-12-17 | 2012-12-19 | 250,000 | $8.08 | $2.02M | 2,950,790 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-14 | 2012-12-18 | 249,249 | $0.95 | $236.8K | 6,871,981 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-14 | 2012-12-19 | 249,249 | $0.95 | $236.8K | 6,871,981 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-12 | 2012-12-14 | 399,414 | $1.05 | $419.4K | 7,121,230 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-10 | 2012-12-11 | 139,653 | $1.05 | $146.6K | 7,520,644 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-07 | 2012-12-11 | 230,407 | $1.00 | $230.4K | 7,660,297 | SEC↗ |
| MEIP MEI Pharma, Inc. | J Other deriv | 2012-12-06 | 2012-12-11 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-06 | 2012-12-07 | 235,009 | $1.07 | $251.5K | 7,890,704 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | S Sale | 2012-12-05 | 2012-12-07 | 154,836 | $1.18 | $182.7K | 8,125,713 | SEC↗ |
| MEIP MEI Pharma, Inc. | J Other | 2012-12-03 | 2012-12-05 | 3,478,245 | — | $0 | 3,832,081 | SEC↗ |
| GDP GOODRICH PETROLEUM CORP | A Award | 2012-05-17 | 2012-05-21 | 6,000 | $13.38 | $80.3K | 76,600 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | P Buy | 2012-01-27 | 2012-01-30 | 13,900 | $4.46 | $62.0K | 8,301,049 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | P Buy | 2012-01-27 | 2012-01-30 | 4,000 | $4.50 | $18.0K | 8,305,049 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | P Buy | 2012-01-27 | 2012-01-30 | 4,000 | $4.43 | $17.7K | 8,287,149 | SEC↗ |
| CHTP Chelsea Therapeutics Inter | P Buy | 2012-01-23 | 2012-01-24 | 40,000 | $4.80 | $192.0K | 8,283,149 | SEC↗ |